These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 9604227

  • 1. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
    Sabri O, Schulz G, Zimny M, Schreckenberger M, Zimny D, Wagenknecht G, Kaiser HJ, Dohmen BM, Bares R, Büll U.
    Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
    [Abstract] [Full Text] [Related]

  • 2. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
    Sabri O, Zimny M, Schreckenberger M, Reinartz P, Nowak B, Ostwald E, Schäfer W, Block S, Setani K, Büll U.
    Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
    [Abstract] [Full Text] [Related]

  • 3. [Effect of antithyroid medication on the effective half-life and uptake of 131-iodine following radioiodine therapy].
    Moka D, Voth E, Schicha H.
    Nuklearmedizin; 1997 Apr; 36(3):87-92. PubMed ID: 9162907
    [Abstract] [Full Text] [Related]

  • 4. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE, Michanek AM, Holmberg EC, Fink M.
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [Abstract] [Full Text] [Related]

  • 5. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
    Kobe C, Eschner W, Sudbrock F, Weber I, Marx K, Dietlein M, Schicha H.
    Nuklearmedizin; 2008 Feb; 47(1):13-7. PubMed ID: 18278207
    [Abstract] [Full Text] [Related]

  • 6. [Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].
    Urbannek V, Voth E, Moka D, Schicha H.
    Nuklearmedizin; 2001 Aug; 40(4):111-5. PubMed ID: 11556200
    [Abstract] [Full Text] [Related]

  • 7. Does an individual estimation of halflife improve the results of radioiodine therapy of Graves' disease?
    Schneider P, Körber C, Körber-Hafner N, Hänscheid H, Reiners C.
    Nuklearmedizin; 2002 Dec; 41(6):240-4. PubMed ID: 12520660
    [Abstract] [Full Text] [Related]

  • 8. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M, Moka D, Reinholz U, Schmidt M, Schomäcker K, Schicha H, Wellner U.
    Nuklearmedizin; 2007 Dec; 46(3):77-84. PubMed ID: 17549318
    [Abstract] [Full Text] [Related]

  • 9. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
    Howarth D, Epstein M, Lan L, Tan P, Booker J.
    Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
    [Abstract] [Full Text] [Related]

  • 10. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O, Zimny M, Schreckenberger M, Reinartz P, Ostwald E, Buell U.
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC, Di Martino F, Grosso M, Monzani F, Dardano A, Caraccio N, Mariani G, Lazzeri M.
    Phys Med Biol; 2005 May 07; 50(9):2181-91. PubMed ID: 15843745
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D, Dietlein M, Schicha H.
    Eur J Nucl Med Mol Imaging; 2002 Aug 07; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L, De Palma D, Ceriani L, Vanoli P, Garancini S, Tordiglione M, Tarolo GL.
    Radiol Med; 2000 Dec 07; 100(6):480-3. PubMed ID: 11307510
    [Abstract] [Full Text] [Related]

  • 20. Possibility of limiting the un-justified irradiation in (131)I therapy of Graves' disease: a thyroid mass-reduction based method for the optimum activity calculation.
    Traino AC, Grosso M, Mariani G.
    Phys Med; 2010 Apr 07; 26(2):71-9. PubMed ID: 19800827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.